US 9925271
Targeted pharmacological chaperones
granted A61KA61K31/445A61K47/64
Quick answer
US patent 9925271 (Targeted pharmacological chaperones) held by Marker Gene Technologies, Inc expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Marker Gene Technologies, Inc
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/445, A61K47/64, A61K47/645